PUBLICATIES NEFROLOGIE 2013 Pagina 1 19 6 2014

PUBLICATIES NEFROLOGIE 2013 Pagina 1 19 6 2014 1. Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Stolk RP, Navis GJ, Bakker SJL, Dullaart RPF. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: The PREVEND Study. J Clin Endocrinol Metab. 2013;98:E1352-1359 2. Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: A diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis. 2013;S0272-6386(13)01470-1474 3. Abdulahad WH, Lepse N, Stegeman CA, Huitema MG, Doornbos-Meer van der B, Tadema HH, Rutgers A, Limburg PC, Kallenberg CGM, Heeringa P. Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis. Arthritis Res Ther. 2013; 24;15:R70 4. Altorf-van der Kuil W, Brink EJ, Boetje M, Siebelink E, Bijlsma S, Engberink MF, Veer PV, Tomé D, Bakker SJL, Baak MA van, Geleijnse JM. Identification of biomarkers for intake of protein from meat, dairy products and grains: a controlled dietary intervention study. Br J Nutr. 2013;110:810-822 5. Andrésdóttir G, Bakker SJL, Hansen HP, Parving HH, Rossing P. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes. Diabet Med. 2013;563-566 6. Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, Bakker SJL, Muller Kobold AC, Oeveren W van, Struck J, Jong PE de, Franssen CFM. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: A cross-sectional study. Am J Kidney Dis. 2013; S0272-6386:01471-476 7. Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, Jong PE de, Westerhuis R, Franssen CFM. Changes in left ventricular diastolic function during hemodialysis sessions. Am J Kidney Dis. 2013;62:549-556 8. Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, Jong PE de, Bakker SJL, Franssen CFM. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clin Res Cardiol. 2013;102:439-445 9. Baia LC, Humalda JK, Vervloet MG, Navis GJ, Bakker SJL, Borst MH de; NIGRAM Consortium. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8:1968-1978 10. Bakker SJL. Chronic kidney disease: Defining clinical cut-offs for albumin:creatinine ratio. Nat Rev Nephrol. 2013;9:710-712 11. Berg E van den, Engberink MF, Brink EJ, Baak MA van, Gans ROB, Navis GJ, Bakker SJL. Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr. 2013;109:1463-1470 12. Berndt SI, Gustafsson S, Mägi R, Ganna A, Wheeler E, Feitosa MF et al including Navis GJ. Genomewide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45:501-512 13. Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61:420-429 14. Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJL, Groenier KH, Struck J, Jong PE de, Bilo HJ, Kleefstra N, Gansevoort RT. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia. 2013;56:1680-1688

PUBLICATIES NEFROLOGIE 2013 Pagina 2 19 6 2014 15. Boertien WE, Meijer E, Jong PE de, Bakker SJL, Czerwiec FS, Struck J, Oberdhan D, Shoaf SE, Krasa HB, Gansevoort RT. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int. 2013;84:1278-1286 16. Brouwers FP, Boer RA de, Harst P van der, Voors AA, Gansevoort RT, Bakker SJL, Hillege HL, Veldhuisen DJ van, Gilst WH van. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34:1424-1431 17. CLOTS (Clots in Legs Or stockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G including Navis GJ. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382:516-524 18. Damman J, Seelen MAJ. Mannan binding lectin: a two-faced regulator of renal allograft injury? Kidney Int. 2013;83:191-193 19. Deetman PE, Bakker SJL, Dullaart RPF. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12:166 20. Dijk S van, Beukel TO van den, Kaptein AA, Honig A, le Cessie S, Siegert CE, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group including collaborators Stegeman CA et al. How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and noncardiovascular mortality in incident patients on chronic dialysis. J Psychosom Res. 2013;74:511-517 21. Eersel ME van, Joosten JMH, Gansevoort RT, Dullaart RPF, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One. 2013;8:e82991 22. Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol. 2013; 9;168:3550-3555 23. Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Response to letter by Balta et al. Int J Cardiol. 2013;169:89 24. Engel MF, Postma DF, Hulscher ME, Teding van Berkhout F, Emmelot-Vonk MH, Sankatsing S, Gaillard CAJM, Bruns AH, Hoepelman AI, Oosterheert JJ. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J. 2013;41:123-130 25. Franssen CFM, Navis GJ. Chronic kidney disease: RAAS blockade and diastolic heart failure in chronic kidney disease. Nat Rev Nephrol. 2013;9:190-192 26. Gaillard CAJM, Schiffelers RM. Red blood cell: barometer of cardiovascular health? Cardiovasc Res 2013;98:3-4 27. Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA,EN et al including Gansevoort RT; CARDIOGRAM, METASTROKE, LifeLines Cohort Study. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013;22:1663-1678 28. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339-352 29. Grootendorst DC, Elliott EG, Michels WM, Gansevoort RT, Halbesma N. Lead and CKD. Nephrol Dial Transplant. 2013;28:e

PUBLICATIES NEFROLOGIE 2013 Pagina 3 19 6 2014 30. Guo DH, Parikh SJ, Chao J, Pollock NK, Wang X, Snieder H, Navis GJ, Wilson JG, Bhagatwala J, Zhu H, Dong Y. Urinary prostasin excretion is associated withadiposity in nonhypertensive African-American adolescents. Pediatr Res. 2013;74:206-210 31. Gui J, Moore JH, Williams SM, Andrews P, Hillege HL, Harst P van der, Navis GJ, Gilst WH van, Asselbergs FW, Gilbert-Diamond D. A simple and computationally efficient approach to multifactor dimensionality reduction analysis of gene-gene interactions for quantitative traits. PLoS One. 2013;8:e66545 32. Haas EC de, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker SJL, Roon AM van, Postma A, Wolffenbuttel BH, Hoekstra HJ, Leeuwen FE van, Sleijfer DT, Gietema JA.Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol. 2013;24:749-755 33. Hallan SI, Gansevoort RT. Moderator's view: Estimating glomerular filtration rate--the past, present and future. Nephrol Dial Transplant. 2013;28:1404-1406 34. Hateren KJ van, Landman GW, Kleefstra N, Groenier KH, Struck J, Navis GJ, Bakker SJL, Houweling ST, Meer K van der, Bilo HJ. The midregional fragment of pro-a-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25). Diabetes Care. 2013;36:1347-1352 35. Hellemons ME, Lambers Heerspink HJ, Gansevoort RT, Zeeuw D de, Bakker SJL. High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes. J Hypertens. 2013;31:805-812 36. Hoed M den, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segrè AVet al including Navis GJ. Global BPgen Consortium; CARDIoGRAM Consortium; PR GWAS Consortium, Pfeufer A; QRS GWAS Consortium, Sotoodehnia N; QT-IGCConsortium, Newton-Cheh C; CHARGE-AF Consortium, Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45:621-631 37. Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M et al including Gansevoort RT, Navis GJ. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62:1966-1976 38. Cooper JA, Palmen J, et al including Gansevoort RT, Navis GJ. Secretory phospholipase A2-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62:1966-1976 39. Hoogen MW van den, Hesselink DA, Son WJ van, Weimar W, Hilbrands LB. Treatment of steroidresistant acute renal allograft rejection with alemtuzumab. Am J Transplant. 2013;13:192-196 40. Hoogen MW van den, Kho MM, Abrahams AC, Zuilen AD van, Sanders JSF, Dijk MC van, Hilbrands LB, Weimar W, Hoitsma AJ. Effect of a single intraoperative high-dose ATG-fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: A randomized study. Exp Clin Transplant. 2013;11:134-141 41. Hu YJ, Berndt SI, Gustafsson S, Ganna A; Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Hirschhorn J, North KE, Ingelsson E, Lin DY including Navis GJ. Meta-analysis of genelevel associations for rare variants based on single-variant statistics. Am J Hum Genet. 2013;93:236-248 42. Jager DJ de, Halbesma N, Krediet RT, Boeschoten EW, le Cessie S, Dekker FW, Grootendorst DC; NECOSAD study group including collaborators Stegeman CA et al. Is the decline of renal function different before and after the start of dialysis? Nephrol Dial Transplant. 2013;28:698-705 43. Joode AAE de, Sanders JSF, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8:1709-1717 44. Joosten JMH, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44:1543-1549

PUBLICATIES NEFROLOGIE 2013 Pagina 4 19 6 2014 45. Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2013;61:1161-1167 46. Joosten MM, Gansevoort RT, Mukamal KJ, Harst P van der, Geleijnse JM, Feskens EJ, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97:1299-1306 47. Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Response to Lowered magnesium in hypertension. Hypertension. 2013;62:e20 48. Kallenberg CGM, Stegeman CA, Abdulahad WH, Heeringa P. Pathogenesis of ANCA-associated vasculitis: New possibilities for intervention. Am J Kidney Dis. 2013;62:1176-1187 49. Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BHR, Dullaart RPF; PREVEND Study Group. Common variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/highdensity lipoprotein cholesterol ratio. J Clin Lipidol. 2013;7:56-64 50. Katta K, Boersema M, Adepu S, Rienstra H, Celie JW, Mencke R, Molema G, Goor H van, Berden JH, Navis GJ, Hillebrands JL, van den Born J. Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction. Am J Pathol. 2013;183:1571-1584 51. Klein Hesselink EN, Klein Hesselink MS, Bock GH de, Gansevoort RT, Bakker SJL, Vredeveld EJ, Horst-Schrivers AN van der, Horst IC van der, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD. Longterm cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J Clin Oncol. 2013;10;31:4046-4053 52. Klooster A, Larkin JR, Wiersema-Buist J, Gans ROB, Thornalley PJ, Navis GJ, Goor H van, Leuvenink HG, Bakker SJL. Are brain and heart tissue prone to the development of thiamine deficiency? Alcohol. 2013;47:215-221 53. Klooster A, Hofker HS, Navis GJ, Homan van der Heide JJ, Gans ROB, Goor H van,leuvenink HG, Bakker SJL. Nonesterified fatty acids and development of graft failure in renal transplant recipients. Transplantation. 2013;95:1383-1389 54. Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D et al including Bakker SJL, Navis GJ; LifeLines Cohort Study; DIAGRAM Consortium; ICBP Consortium; MAGIC Consortium including Navis GJ. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45:145-154 55. Krikken JA, Lely AT, Bakker SJL, Borghuis T, Faas MM, Goor H van, Navis GJ, Bakker WW. Hemopexin activity is associated with angiotensin II responsiveness in humans. J Hypertens. 2013;31:537-541 56. Kuipers J, Usvyat LA, Oosterhuis JK, Dasselaar JJ, Jong PE de, Westerhuis R, Sands JJ, Wang Y, Kotanko P, Franssen CFM. Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. Am J Kidney Dis. 2013;62:779-788 57. Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis GJ, Dullaart RPF. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 2013;226:459-465 58. Kwakernaak AJ, Zelle DM, Bakker SJL, Navis GJ. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24:987-994

PUBLICATIES NEFROLOGIE 2013 Pagina 5 19 6 2014 59. Kwakernaak AJ, Toering TJ, Navis GJ. Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics. Nephrol Dial Transplant. 2013;Suppl 4:iv42-49 60. Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, Boer RA de, Navis GJ. Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N- acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. J Hypertens. 2013;31:2425-32 61. Lambers Heerspink HJ, Borst MH de, Bakker SJL, Navis GJ. Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat Rev Nephrol. 2013;9:112-121 62. Leer-Buter CC van, Sanders JSF, Vroom HE, Riezebos-Brilman A, Niesters HG. Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations. J Clin Virol. 2013;58:422-426 63. Matsushita K, Ballew SH, Astor BC, Jong PE de, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium. Cohort profile: the chronic kidney disease prognosis consortium. Int J Epidemiol. 2013;42:1660-1668 64. Metalidis C, Vuuren SH van, Broekhuizen R, Lerut E, Naesens M, Bakker SJL, Wetzels JF, Goldschmeding R, Kuypers DR. Urinary connective tissue growth factor is associated with human renal allograft fibrogenesis. Transplantation. 2013;96:494-500 65. Meijer E, Drenth JP, d'agnolo H, Casteleijn NF, Fijter JW de, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium. Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 2013;S0272-6386(13)01391-1397 66. Miloslavsky E, Specks U, Merkel P, Seo P, Spiera R, Langford C, Hoffman GS, Kallenberg CGM et al including Stegeman CA; for the RAVE-ITN Research Group. Clinical outcomes of remission induction therapy for severe ANCA-Associated vasculitis. Arthritis Rheum. 2013;65:2441-2449 67. Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, Born J van den, Navis GJ, Borst MH de. Urinary vitamin d binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One. 2013;8:e55887 68. Nauta FL, Scheven L, Meijer E, Oeveren W van, Jong PE de, Bakker SJL, Gansevoort RT. Glomerular and Tubular Damage Markers in Individuals with Progressive Albuminuria. Clin J Am Soc Nephrol. 2013;8:1106-1114 69. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, et al including Chronic Kidney Disease Prognosis Consortium. Collaborators including Gansevoort RT, Jong PE de. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f324 70. Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Fried LF, Newman AB, Katz R, Satterfield S, Harris TB, Sarnak MJ, Siscovick D, Shlipak MG. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol. 2013;23:106-111 71. Özyilmaz A, Bakker SJL, Zeeuw D de, Jong PE de, Gansevoort RT; PREVEND Study Group. Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. Nephrol Dial Transplant. 2013;28:2805-2815 72. Paul DS, Albers CA, Rendon A, Voss K, Stephens J; HaemGen Consortium, Harst P van der, Chambers JC, Soranzo N, Ouwehand WH, Deloukas P including collaborators Navis GJ et al. Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res. 2013;23:1130-1141

PUBLICATIES NEFROLOGIE 2013 Pagina 6 19 6 2014 73. Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, Kilpeläinen TO, Esko T et al DIAGRAM Consortium, MAGIC Investigators, Hottenga JJ, Prokopenko I, Waite LL, Harris TB, Smith AV, Shuldiner AR et al including Bakker SJL, Navis GJ. Sex-stratified genome-wide association studies Including 270,000 Individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9:e1003500 74. Reznichenko A, Sinkeler SJ, Snieder H, Born J van den, Borst MH de, Damman J, Dijk MC van, Goor H van, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJL, Seelen MAJ, Navis GJ. SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics.2013;45:201-209 75. Riezebos-Brilman A, Verschuuren EA, Son WJ van, Imhoff GW van, Brügemann J, Blokzijl H, Niesters HG. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol. 2013;58:509-514 76. Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, Hateren van KJ, Struck J, Navis GJ, Bilo HJ, Bakker SJL. Copeptin, a surrogate marker for arginine vasopressin, Is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care. 2013;36:3201-3207 77. Roscioni SS, Zeeuw D de, Hellemons ME, Mischak H, Zürbig P, Bakker SJL, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Lambers Heerspink HJ. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia. 2013;56:259-267 78. Roth AJ, Ooi JD, Hess JJ, Timmeren MM van, Berg EA, Poulton CE, McGregor J, Burkart M et al including Stegeman CA et al. Epitope specificity determines pathogenicity and detectability in ANCAassociated vasculitis. J Clin Invest. 2013;123:1773-1783 79. Russcher M, Koch BPC, Nagtegaal JE, Ittersum FJ van, Rasker-de Jong PCM, Hagen EC, Dorp WT van, Gabreëls B, Wildbergh TX, Westerlaken MML van der, Gaillard CAJM, Wee PM ter. Long-term effects of melatonin on quality of life and sleep in hemodialysis patients (Melody study): randomized controlled trial. Br J Clin Pharmacol. 2013;76:668-679 80. Scheven L, Halbesma N, Jong PE de, Zeeuw D de, Bakker SJL, Gansevoort RT. Predictors of progression in albuminuria in the general population: results from the PREVEND cohort. PLoS One. 2013;8:e61119 81. Scheven L, Velde M van der, Lambers Heerspink HJ, Jong PE de, Gansevoort RT. Isolated microalbuminuria indicates a poor medical prognosis. Nephrol Dial Transplant. 2013;28:1794-1801 82. Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJL, Kema IP, Gilst WH van, Veldhuisen DJ van, Hillege HL, Boer RA de. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166:357-364 83. Schulz T, Niesing J, Homan van der Heide JJ, Westerhuis R, Ploeg RJ, Ranchor AV. Perceived health after kidney transplantation: a cross-sectional comparison of long-term and short-term cohorts. Transplant Proc. 2013;45:2184-2190 84. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369:932-943 85. Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med. 2013;369:2459 86. Sim X, Jensen RA, Ikram MK, Cotch MF, Li X, MacGregor S, Xie J, Smith AV et al; Wellcome Trust Case Control Consortium 2, Global BPGen Consortium. Collaborators including Navis GJ, Jong PE de. Genetic loci for retinal arteriolar microcirculation. PLoS One. 2013;8:e65804

PUBLICATIES NEFROLOGIE 2013 Pagina 7 19 6 2014 87. Sinkeler SJ, Kwakernaak AJ, Bakker SJL, Shahinfar S, Esmatjes E, Zeeuw D de, Navis GJ, Lambers Heerspink HJ, Heerspink. Creatinine excretion rate and mortality in type 2 diabetes and Nephropathy. Diabetes Care. 2013;36:1489-1494 88. Snijder PM, Berg E van den, Whiteman M, Bakker SJL, Leuvenink HG, Goor H van. Emerging role of gasotransmitters in renal transplantation. Am J Transplant. 2013;13:3067-3075 89. Souza AW de, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CGM. Is serum HMGB1 a biomarker in ANCA-Associated vasculitis? Arthritis Res Ther.2013;15:R104 90. Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, Jong PE de, Navis GJ, Gansevoort RT. Tubular secretion of creatinine in autosomal dominant polycystic Kidney ddisease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations. Am J Kidney Dis. 2013;62:531-540 91. Spithoven EM, Bakker SJl, Kootstra-Ros JE, Jong PE de, Gansevoort RT; DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46:1611-1614 92. Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM et al including Stegeman CA; RAVE-ITN Research Group. Efficacy of remission-induction regimens for ANCAassociated vasculitis. N Engl J Med. 2013;369:417-427 93. Spithoven EM, Bakker SJL, Kootstra-Ros JE, Jong PE de, Gansevoort RT; for the DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46:1611-1614 94. Suttorp MM, Hoekstra T, Mittelman M, Ott I, Franssen CFM, Dekker FW. Effect of erythropoiesisstimulating agents on blood pressure in pre-dialysis patients.plos One. 2013;8:e84848 95. Teunissen-Beekman KF, Dopheide J, Geleijnse JM, Bakker SJL, Brink EJ, Leeuw PW de, Serroyen J, Baak MA van. Blood pressure decreases more after high-carbohydrate meals than after high-protein meals in overweight adults with elevated blood pressure, but there is no difference after 4 weeks of consuming a carbohydrate-rich or protein-rich diet. J Nutr. 2013;143:424-429 96. Tielemans SM, Altorf-van der Kuil W, Engberink MF, Brink EJ, Baak MA van, Bakker SJL, Geleijnse JM. Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies. J Hum Hypertens. 2013;27:564-571 97. Tielemans SM, Geleijnse JM, Baak MA van, Engberink MF, Brink EJ, Jong PE de, Gansevoort RT, Bakker SJL; PREVEND Study Group. Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the PREVEND study. J Hypertens. 2013;31:1564-1569 98. Toering TJ, Navis GJ, Lely AT. The role of the VEGF-C signaling pathway in preeclampsia? J Reprod Immunol. 2013;100:128 99. Torres VE, Gansevoort RT, Czerwiec FS. Tolvaptan in autosomal dominant polycystic kidney disease. N Engl J Med. 2013;368:1259 100. Tuin J, Sanders JSF, Buhl BM, Beek AP van, Stegeman CA. Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life? Arthritis Res Ther. 2013;15:R117 101. Turin TC, Coresh J, Tonelli M, Stevens PE, Jong PE de, Farmer CK, Matsushita K, Hemmelgarn BR. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013;83:684-691 102. Vader P, Fens MH, Sachini N, Oirschot BA van, Andringa G, Egberts AC, Gaillard CAJM, Rasmussen JT, Wijk R van, Solinge WW van, Schiffelers RM. Taxol( )-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor( ) EL. Nanomedicine (Lond). 2013;8:1127-1135 103. Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol. 2013;8:1685-1693

PUBLICATIES NEFROLOGIE 2013 Pagina 8 19 6 2014 104. Verweij N, Mahmud H, Mateo Leach I, Boer RA de, Brouwers FP, Yu H, Asselbergs FW, Struck J, Bakker SJL, Gansevoort RT, Munroe PB, Hillege HL, Veldhuisen DJ van, Gilst WH van, Silljé HH, Harst P van der. Genome-wide association study on plasmalevels of midregional-proadrenomedullin and C- terminal-pro-endothelin-1. Hypertension. 2013;61:602-608 105. Werkhoven MB van, Damman J, Daha MR, Krikke C, Goor H van, Son WJ van, Hillebrands JL, Dijk MC van, Seelen MAJ. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol. 2013;53:237-245 106. Werkhoven MB van, Damman J, Dijk MC van, Daha MR, Jong IJ de, Leliveld A, Krikke C, Leuvenink HG, Goor H van, Son WJ van, Olinga P, Hillebrands JL, Seelen MAJ. Complement mediated renal inflammation induced by donor brain death: Role of renal C5a-C5aR interaction. Am J Transplant. 2013;13:875-882 107. Zelle DM, Corpeleijn E, Deinum J, Stolk RP, Gans ROB, Navis GJ, Bakker SJL. Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 2013;36:1926-1932 108. Zelle DM, Kok T, Dontje ML, Danchell EI, Navis GJ, Son WJ van, Bakker SJL, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013;27:E484-490 DISSERSATIES Berg van den E Nutrition and cardiovascular health in renal transplant recipients Promtores: prof dr GJ Navis, prof dr ROB Gans Copromotor: dr SJL Bakker Groningen, 06-03-2013 Alkhalaf A Novel approaches in diabetic Nephropathy Promotores: prof dr GJ Navis, prof dr HJG Bilo Copromotoren: dr SJL Bakker, dr N Kleefstra Groningen, 10-04-2013 Abbasi A Biomarkers and prediction models for type 2 diabetes and diabetes related outcomes Promotores: prof dr RP Stolk and prof dr GJ Navis Copromotores: dr SJL. Bakker, dr. ir. E. Corpeleijn and r. ir. JW. Beulens Groningen 01-05-2013 Smink PA Biomarkers and assessment of drug efficacy in cardiovascular disease Promotor: prof dr D de Zeeuw Copromotores: dr HJ Lambers Heerspink, dr SJL Bakker

PUBLICATIES NEFROLOGIE 2013 Pagina 9 19 6 2014 Groningen 08-05-2013 Velde van der M Renal risk markers and patient prognosis in chronic kidney disease Promotor: prof dr PE de Jong Copromotor: dr RT Gansevoort Groningen 12-06-2013 Klooster A Thiamine, fasting and the kidney Promotor: prof dr H van Goor Copromotores: dr SJL Bakker, dr HGD Leuvelink Groningen 12-06-2013 Zelle DM Lifestyle, the next target for intervention in renal transplant recipients Promotores: prof dr GJ Navis, prof dr RP Stolk Copromotores: dr SJL Bakker, dr ir E Corpeleijn Groningen 01-07-2013 HOOFDSTUK BOEK